Potential Pharmacokinetic Interaction Between Selexipag and Midazolam in Healthy Male Subjects
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the effect of repeated doses of selexipag on
the pharmacokinetics of a single oral dose of midazolam (i.e., how long and how much
midazolam is present in the blood)